Get AI Briefings, Transcripts & Alerts on Local & National Government Meetings — Forever.
Medical and prevention experts urge preserving potency caps and opposing larger cannabis packages in S.278
Loading...
Summary
Representatives of Vermont medical societies and a Burlington prevention coalition told the House committee they support retaining THC potency caps, existing advertising limits and current excise tax allocations and warned higher package sizes and public consumption pilots could increase youth harms.
Jill Satafaran, representing the Medical Society, the Pediatrics of Vermont Chapter and Vermont Family Physicians, and Mariah Flynn, coalition director for the Burlington Partnership for a Healthy Community, told the House committee they were concerned about provisions in S.278 that could increase youth access and normalize higher‑potency products.
Satafaran said the medical community is "not opposed" to the Senate‑passed S.278 overall but urged maintaining three core protections: a 60% THC cap on solid concentrates, existing advertising regulations and current excise tax allocations (she noted about 30% of excise receipts fund substance misuse prevention programs). She explicitly opposed increasing package size from 100 milligrams to 200 milligrams, citing emergency‑department risks when children accidentally ingest edibles and referencing the American College of Medical Toxicology's 2025 statement recommending a 50 mg package cap.
Flynn, a certified prevention specialist who directs a Burlington substance‑misuse prevention coalition, told the committee Vermont reports among the highest state rates of cannabis use and that local school surveys show vaping and cannabis are top concerns for students. She urged the legislature to prioritize funding for prevention and public education alongside any commercialization changes and warned that new public consumption or larger package sizes could normalize use for young people who walk daily past multiple cannabis shops.
Both witnesses requested the committee preserve the bill’s public‑health safeguards as it considers market expansions such as events, cafes and delivery pilot programs. Committee members asked Flynn for data sources and she offered to provide links to the National Survey on Drug Use and Health and related local survey results.
The committee took no formal action during the hearing and said it will review written materials submitted by public‑health groups.
